U.S.-China Trade Dispute Fans Worries About What's Next for the Stock Market

Morgan Stanley strategist Michael Wilson warns that escalating U.S.-China trade tensions could trigger the first significant U.S. stock market correction since April, projecting an S&P 500 decline exceeding 15% without de-escalation. He recommends healthcare stocks as a hedge against policy uncertainty, while identifying semiconductors, quantum computing, and crowded growth stocks as having the highest downside risk. This cautious outlook is supported by Ned Davis Research, which anticipates prolonged negotiations, with Morgan Stanley's bear case scenario projecting an S&P 500 target of 4,900 if tariffs escalate further, negating their 2026 market recovery thesis.

Analysis

Morgan Stanley equity strategist Michael Wilson warns that escalating U.S.-China trade tensions could trigger the "first meaningful correction" in U.S. stocks since April, potentially leading to an S&P 500 decline exceeding 15% without de-escalation. This cautious outlook is supported by recent market action, including a climb in gold prices, increased volatility, and vulnerability in tech stocks like Nvidia and Intel, which have dragged on broader market indexes despite the S&P 500, Dow, and Nasdaq remaining near record levels. Sentiment data indicates a strongly negative outlook for broad market indices (SPY: -0.7, QQQ: -0.6).

Wilson identifies healthcare stocks as the "best hedge" against policy uncertainty and a "preferred" defensive sector, alongside quality companies with strong fundamental characteristics. Conversely, semiconductors, quantum computing, and "crowded stocks" are highlighted as having the "most downside risk," with consumer discretionary goods also facing an underweight recommendation due to potential tariff impacts. Per-ticker sentiment for NVDA and INTC is notably negative at -0.5.

Ned Davis Research economists do not anticipate a quick resolution to trade tensions, citing China's ability to offset weaker U.S. demand with strong exports elsewhere. Morgan Stanley's bear case scenario projects an S&P 500 target of 4,900, representing a more than 25% decline from current levels, should a 100% tariff on China become effective by November 1, which would negate their 2026 market recovery thesis.

Key Decisions for Investors

• Investors should consider re-evaluating portfolio allocations towards defensive sectors like healthcare and high-quality companies with strong fundamentals, as these are identified as potential hedges against trade policy uncertainty.
• Assess exposure to high-risk sectors such as semiconductors, quantum computing, and crowded growth stocks, given their identified significant downside risk in an escalating trade environment.
• Monitor U.S.-China trade negotiations closely, particularly the potential for further tariff escalations by November 1, as this could trigger a substantial market correction and negate current recovery theses.